Tag: medicines
What member states must get right for consumers in EU pharma reform
The European Union’s pharmaceutical legislation is undergoing its biggest reform in two decades. It is the moment for member states to pay particular attention to what consumers need, writes Ancel.la Santos.
When medicines cost an arm and a leg. And an eye
Last week, a pharmaceutical company was accused of intentionally inflating the price of one of its medicines by 2,000%[1]. Does this kind of news seem like déjà vu? Most probably, because escalating medicine prices are getting more and more coverage....
A bitter pill to swallow
The trend is clear: the cost of medicines is increasing. Many EU healthcare systems are now spending more than ever before on pharmaceutical products. At a time when the words ‘economic crisis’ rhyme with ‘normality’, consumers are having to shoulder...
Health: Is TTIP the pill for all our ills?
Transatlantic cooperation, done properly, could have a positive impact on consumers on both sides of the Atlantic in various areas, including health. Nevertheless, reading the EU’s positions on the pharmaceutical and medical devices[1] (e.g. pace makers, hip implants) chapters of...